SavedAdd your journal

Journals / KONURALP TIP DERGİSİ / 2022 / Cilt: 14 - Sayı: 3

The Effect of Periodic Examination Time Interval and Frequency After “Percutaneous Coronary Intervention” on Experiencing Second "Acute Coronary Syndrome"

“Perkütan Koroner Girişim” Sonrası Periyodik Muayene Zaman Aralığı ve Sıklığının İkinci "Akut Koroner Sendrom" Yaşanmasına Etkisi

Yakup BALABAN
Kahraman COŞANSU
Pages
454–460
Publication Date
2022-10-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: The aim of this study was to evaluate the effect of follow-ups of patients who underwent percutaneous coronary intervention (PCI) at short (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to evaluate the effect of follow-ups of patients who underwent percutaneous coronary intervention (PCI) at short (
📊
Key Findings & Data:Objective: The aim of this study was to evaluate the effect of follow-ups of patients who underwent percutaneous coronary intervention (PCI) at short (
💡
Conclusion & Impact:Objective: The aim of this study was to evaluate the effect of follow-ups of patients who underwent percutaneous coronary intervention (PCI) at short (
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Akut koroner sendrom · anjiyoplasti · düzenli klinik takip

Abstract

Objective: The aim of this study was to evaluate the effect of follow-ups of patients who underwent percutaneous coronary intervention (PCI) at short (

Özet

Amaç: Bu çalışmayla perkütan koroner(PKG) girişim geçiren hastaların 6 aydan kısa ve uzun sürelerle kontrol edilmelerinin ve medyanın akut koroner sendrom(AKS) yaşamalarına etkisi araştırılmıştır. Gereç ve Yöntem: Kliniğimizde iki kez PKG geçirmiş 281 hastanın bilgileri retrospektif olarak incelenmiştir. Bu hastalar 6 ay ve daha kısa süreli düzenli takibe gelenler (Grup 1, n: 157) ve 6 aydan uzun sürelerle veya düzensiz takibe gelenler (Grup2, n: 124) ve olarak iki gruba ayrılmışlardır. Düzenli takiplerin yeterli statin kullanımında, akut koroner sendrom geçirmede ve kardiyak sebeple ölüm üzerinde etkili olup olmadığı araştırılmıştır. Bulgular: AKS sıklığı (87.8 e karşı 20.6%

🔖

Cite This Article

BALABAN, Y., COŞANSU, K. (2022). The Effect of Periodic Examination Time Interval and Frequency After “Percutaneous Coronary Intervention” on Experiencing Second "Acute Coronary Syndrome". KONURALP TIP DERGİSİ, Cilt: 14 - Sayı: 3, 454–460. https://ajindex.com/articles/686620

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. French JK, Burgess S, Chew DP. Re-infarction after primary percutaneous coronary intervention. Curr Opin Cardiol. 2015
  2. Eyuboglu M. Survival after primary percutaneous coronary intervention. Int J Cardiol. 2016
  3. 953 [3]- Bromage DI, Jones DA, Rathod KS, Grout C, Iqbal MB. Outcome of 1051 Octogenarian Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Observational Cohort From the London Heart Attack Group. J Am Heart Assoc. 2016
  4. Şahi̇nkuş, S, Aksoy, M, Aydın, E, Eynel, E, Akçay, Ç, Kocayi̇ği̇t, İ, Can, Y, Kılıç, H, Akdemi̇r, R. "2018 Yılında Tek Merkezde Primer Perkutan Koroner Girişim Yapılan Hastaların Klinik Özellikleri, Anjiyografi İşleminin ve Hastane İçi Klinik Sonuçların Analizi". Sakarya Tıp Dergisi 10 (2020 ): 197-204 [5]- Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006
  5. Barindik, Uzun N, Baysan M, Kirilmaz O, Sağ A, Erinç C, Kiliçarslan K, Yokuşoğlu F, Genç M, Demirtaş C. Revaskülarizasyon yapılamayan semptomatik koroner arter hastalarında agresif lipid düşürücü tedavinin etkinliği / Effect of aggressive lipid lowering treatment in symptomatic coronary artery disease patients who are hot suitable for revascularization. Ertan Medical Network Kardiyoloji 2003,4:283-286 [7]- Task Force Members
  6. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013
  7. Galliver M. “Media coverage of statins may have led to 2000 cardiovascular events.” BMJ. 2016 Jun 30
  8. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001
  9. Becker RC, Meade TW, Berger PB, Ezekowitz M, O'Connor CM, Vorchheimer DA, et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008
  10. 776S-814. [11]- Forster AJ, Murff HJ, Peterson JF, G